HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 11, November 2018 – The Asian Cancer - War on liver cancer       » 2018 Nobel Prize in Physiology or Medicine winners       » Women more prone to selected chemotherapy side effects       » Tibetan fungus could help fight liver cancer       » Standards for TCM decoction to be applied globally       » RMB200 million donation to build Tsinghua University Biomedical Sciences Building      
EYE ON CHINA
Medopad and Tencent develop advanced AI for Parkinson’s disease
New motor function test allows patients to be assessed outside of the clinical setting in just 3 minutes – 10 times faster than the standard clinician appointment

A new project will use AI technology to assess the motor function of people with Parkinson’s in a real-world setting to greatly reduce evaluation time, improve efficiency, and reduce costs.

Working together on the joint research and development initiative are British HealthTech company Medopad, Chinese tech giant Tencent, and Ray Chaudhuri, Professor of Movement Disorders and Director of the Parkinson's Centre of Excellence at King's College Hospital in London.

Dr. Wei Fan, head of Tencent Medical AI Lab cited Parkinson’s disease as the third most common condition in China after diabetes and cancer.

Currently, Parkinson's disease motor function assessment takes more than 30 minutes in a clinical setting. The doctor asks the patient to perform a series of actions and scores the patient’s motor function against a standard scale based on multiple factors such as distance, amplitude, and action frequency. The scoring is ultimately assigned based on the assessor’s observations, therefore lacks standardised quantitative indicators, resulting in a low capacity to detect small variations and leaving the assessment prone to generating inconsistent results.

To standardise this test and enable patients to complete it remotely, Medopad and Tencent Medical AI Lab are using motion video analysis technology that leverages deep learning and image recognition to quantify motor functions. The AI model was developed by setting hundreds of identifiable key nodes on the human body and using detectors to track the frequency, distance, and changes in angles and speeds of movements. With the aid of this AI technology, Tencent’s Parkinson's disease motor function intelligent assessment system can quantify and improve the accuracy of motion evaluation.

Medopad’s smartphone technology allows patients to perform a motor function assessment outside of the clinical setting, share the results in real-time, and enable doctors to more efficiently and effectively evaluate a patient’s progress. This technology will revolutionise the way doctors carry out their medical consultation: patients will be able to be assessed outside of the clinical setting in just three minutes – 10 times faster than the standard clinician appointment.

The technology has been validated in China, the UK is expected to be next.

Source: Medopad

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Doctor Robot - The digital healthcare revolution
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy